Talk:Lysosomal acid lipase deficiency/Archive 1

Advertising, possible conflict of interest
I have done a general clean-up of the article and also removed some information that may be advertising for a company called Synageva, including a link in the external links sectino which seems to be a disguised link to recruit for Synageva's drug trials.

I also note that the material in question was introduced by two users called "User:Jennhedly" and "User:JennH123". These may be the same person, and may be the same person as Jennifer Hedly, who is listed by LinkedIn as "Admin" at Synageva. If so, then I would like to caution that either or both of the users face a conflict of interest issues in introducing that may be advertising for her (?) employer. --PalaceGuard008 (Talk) 14:16, 10 April 2012 (UTC)

Wolman and CESD
Since all three are considered one disease now, I think we should refer to the disease consistently on the page as LAL-D, and remove the old distinction based on disease onset. Text about historical naming should stay. Thoughts? --FeldBum (talk) 19:51, 1 June 2016 (UTC)
 * am good with that. thanks! Jytdog (talk) 21:05, 1 June 2016 (UTC)